Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis

Wei Qiu, Xinwei Wang, Brian Leibowitz, Hongtao Liu, Nick Barker, Hitoshi Okada, Naohide Oue, Wataru Yasui, Hans Clevers, Robert E. Schoen, Jian Yu, Lin Zhang

Research output: Contribution to journalArticlepeer-review

89 Citations (Scopus)

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as sulindac effectively prevent colon cancer in humans and rodent models. However, their cellular targets and underlying mechanisms have remained elusive. We found that dietary sulindac induced apopto- sis to remove the intestinal stem cells with nuclear or phosphorylated β-catenin in APCMin/+ mice. NSAIDs also induced apoptosis in human colonic polyps and effectively removed cells with aberrant Wnt signaling. Furthermore, deficiency in SMAC, a mitochondrial apoptogenic protein, attenuated the tumor-suppressive effect of sulindac in APC Min/+ mice by blocking apoptosis and removal of stem cells with nuclear or phosphorylated p-catenin. These results suggest that effective chemoprevention of colon cancer by NSAIDs lies in the elimination of stem cells that are inappropriately activated by oncogenic events through induction of apoptosis.

Original languageEnglish
Pages (from-to)20027-20032
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number46
DOIs
Publication statusPublished - 16 Nov 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis'. Together they form a unique fingerprint.

Cite this